The Tax oncoprotein of the type I human T cell leukemia virus (HTLV-I) activates transcription of cellular and viral genes through at least two different transcription factor pathways. Tax activates transcription of the c-fos proto-oncogene by a mechanism that appears to involve members of the cAMP response element binding protein (CREB) and activating transcription factor (ATF) family of DNA-binding proteins. Tax also induces the nuclear expression of the NF-,B family of rel oncogene-related enhancer-binding proteins. We have investigated the potential role of these CREB/ATF and NF-KB/Rel transcription factors in Tax-mediated transformation by analyzing the oncogenic potential of Tax mutants that functionally segregate these two pathways of transactivation. Rat fibroblasts (Rat2) stably expressing either the wild-type Tax protein or a Tax mutant selectively deficient in the ability to induce NF-KB/Rel demonstrated marked changes in morphology and growth characteristics including the ability to form tumors in athymic mice. In contrast, Rat2 cells stably expressing a Tax mutant selectively deficient in the ability to activate transcription through CREB/ATF demonstrated no detectable changes in morphology or growth characteristics. These results suggest that transcriptional activation through the CREB/ATF pathway may play an important role in Tax-mediated cellular transformation. (J. Clin. Invest. 1991. 88:1038-1042
Introduction HTLV-I is the etiologic agent ofthe adult T cell leukemia/lymphoma (ATLL)' (1, 2) , an often aggressive and fatal malig- 1 . Abbreviations used in this paper: ATF, activating transcription factor; ATLL, adult T cell leukemia/lymphoma; CRE, cAMP response element; CREB, CRE-binding protein; HTLV-I, type I human T cell leukemia virus; LTR, long terminal repeat; neoR, neomycin resistance gene.
nancy of mature CD4+ T-lymphocytes. The mechanism of type I human T cell leukemia virus (HTLV-I)-induced cellular transformation appears distinct from that of most other transforming animal retroviruses. The HTLV-I genome neither contains a known oncogene (3) nor does this retrovirus promote cis-activation of endogenous proto-oncogenes by sitespecific integration (4) . Rather, several lines ofevidence suggest that the 40-kD Tax transactivator encoded by the pX region of HTLV-I plays a central role in cellular transformation. Specifically, mice expressing tax as a transgene develop mesenchymal tumors and neurofibromas (5, 6) . Further, overexpression of the tax gene in established mouse or rat fibroblast cell lines results in the transformation of these cells (7) . Similarly, coexpression of the tax gene with the ras oncogene immortalizes primary rat fibroblasts (8) .
Tax is essential for viral replication and potently activates transcription of HTLV-I genes (9, 10) . In addition, Tax transcriptionally activates several cellular genes involved in T cell growth, including IL-2, the alpha chain of the IL-2 receptor (IL-2Ra) and the c-fos proto-oncogene (11) (12) (13) (14) . Tax does not directly bind to the transcriptional regulatory elements within these genes but, rather, acts indirectly through at least two host transcription factor pathways. Tax activation of HTLV-I gene expression involves three imperfectly repeated 21 base enhancer elements present within the proviral long terminal repeat (LTR) (15) (16) (17) . Tax transactivation of the LTR is mediated through constitutively-expressed cellular proteins that bind to a cAMP response element (CRE) present within these 2 1-base pair enhancer elements (18) . Molecular cloning of cDNAs encoding these enhancer-binding proteins has revealed that they represent members of the CRE-binding protein (CREB) and activating transcription factor (ATF) family of DNA-binding proteins (19, 20) . The Tax-responsive sequences in the c-fos promoter also contain a CRE (14) , suggesting that Tax activation of both the HTLV-I LTR and c-fos promoter may involve the CREB/ATF transcription factors. In contrast, Tax activation of the IL-2 and IL-2Ra cellular genes is mediated in part through the induced nuclear expression ofNF-KB (21) . NF-KB binding activity has recently been shown to correspond to a family of transcription factors that share amino terminal sequence homology with the v-rel oncogene (22) (23) (24) 
Methods
Plasmids. The pcTaxWT-neo plasmid constitutively expresses both the HTLV-I tax gene and the selectable bacterial neomycin resistance gene (neoR) (Fig. 1 ). An EcoR I/EcoR I fragment containing neoR under the control of the SV40 early promoter was derived from the pSV2-neo plasmid (26) using the polymerase chain reaction (27) . The pcTaxWT-neo expression vector was constructed by ligating this fragment into the unique EcoR I site within the pcTax plasmid (25). The pcTaxM22-neo and pcTaxM47-neo mutant expression vectors were subsequently constructed by ligating Sac I/Bst ElI fragments from the pcTaxM22 and pcTaxM47 expression vectors (25) into the Sac I/Bst ElI backbone of pcTax-neo. The M22 mutation involves the substitution of the dipeptide alanine-serine for amino acids 137-138 ('3'GlyLeu -. AlaSer) and creates a unique Nhe I restriction site within the tax gene. The M47 mutation substitutes the dipeptide arginine-serine for amino acids 319-320 (319LeuLeu -* ArgSer) and creates a unique BglII restriction site within the tax gene.
Preparation ofRat2 cells stably expressing Tax. The Rat2 cell line (cell repository line 1764; American Type Culture Collection, Bethesda, MD), a phenotypically normal subclone ofthe Fischer rat fibroblast cell line Rat-i (28), was maintained in Iscove's medium supplemented with 5% heat-inactivated fetal calf serum (complete medium). The pSV2-neo, pcTaxWT-neo, pcTaxM22-neo, and pcTaxM47-neo expression vectors were introduced into Rat2 cells by calcium phosphate transfection as previously described (29) . Transfected cells were cultured for 2 d in complete medium then simultaneously selected and cloned by seeding various dilutions of cells into individual microtiter wells (-1000, 300, 100, and 30 cells/well) in complete medium containing the G418 antibiotic (800 .g/ml). After 21 d ofculture, multiple G418-resistant clones were expanded and screened for Tax expression by immunoprecipitation with rabbit anti-Tax antisera. Clones expressing high levels ofTax were selected for further study and maintained in complete media containing G418 (200 .g/ml). (Fig. 2) (Fig. 3 A) . The (Fig. 3 D) . In contrast, Rat2 cells stably ex- (Fig. 3 , B and C). These cells do not undergo contact inhibition at conCMj fluence, forming both microscopic and macroscopic foci after co~7 to14 din culture.
In vitro growth in soft agar. To assess potential differences in the requirement of cell anchorage for growth, each of the Tax-expressing Rat2 clones were cultured in semisolid media.
i.. (Table I, In vivo tumorigenicity. After subcutaneous delivery of 2.5 x 106 viable cells into 4-7-wk-old athymic BALB/c mice, all three ofthe wild-type Tax-expressing cell lines and all six ofthe M22 mutant Tax-expressing lines produced visible tumors at the site of injection within 7-10 d (Table I) . These tumors continued to enlarge, reaching 4 to 12 mm within 3 wk. Tax protein expression was detectable within these tumors as assessed by Western blot analysis (data not shown). In sharp contrast, both the M47 mutant Tax-expressing cell lines and neoR expressing control Rat2 cells did not form detectable tumors during the same period of observation (Table I) .
Discussion
The HTLV-I Tax oncoprotein is a pleiotropic transcriptional activator. Tax activates a variety ofgenes containing functional KB enhancer elements by inducing the nuclear expression of the NF-KB/Rel family of enhancer-binding proteins (22) (23) (24) . Tax also activates the c-fos proto-oncogene by a mechanism that appears to involve the CREB/ATF family oftranscription factors (14, 25) . We have recently identified and characterized tax gene mutants that functionally segregate activation of the NF-KB/Rel and CREB/ATF transcription factor pathways (25). In this study, we have investigated the role of these pathways in Tax-mediated transformation of nonlymphoid rat fibroblasts. Consistent with earlier reports (7), Rat2 cells stably expressing the wild-type Tax protein displayed marked changes in morphology and growth characteristics including anchorage-independent growth and formation of tumors in athymic mice. Rat2 cells stably expressing the M22 Tax mutant, which The development ofATLL appears to represent a multistep process (34) . Early HTLV-I infection is likely characterized by a period of polyclonal T cell proliferation (35) . The ability of Tax to transactivate the genes encoding IL-2 and IL-2Ra raises the possibility that this viral transactivator may initiate the process of leukemogenesis by promoting a period of autocrine T cell growth. The long period of clinical latency that precedes the development of leukemia (36) , and the observation that leukemic cells from ATLL patients are monoclonal (2), suggest that additional cellular events are required for the development of the full malignant phenotype (34) . The nature of these later cellular events remains undefined. However, the ability of Tax to transform nonlymphoid cells by a mechanism that is distinct from its ability to induce NF-KB/Rel raises the intriguing possibility that one or more of these additional events may also be mediated by Tax. Thus, Tax may initiate the process of leukemogenesis by activating the NF-KB/Rel pathway and induce subsequent steps in the transformation process by activating additional cellular genes through CREB/ATF. A more complete understanding of the role of Tax and other viral gene products in the progression to ATLL will require the development of an appropriate animal model of this disease.
